Evidence map›Paper›PMID 38718303›Full record

ArticleOrganic letters2024

Piperazate-Guided Isolation of Caveamides A and B, Cyclohexenylalanine-Containing Nonribosomal Peptides from a Cave Actinomycete.

Mostafa Hagar, Kalindi D Morgan, Spencer D Stumpf, Maya Tsingos, Carmen A Banuelos, Marianne D Sadar, Joshua A V Blodgett, Raymond J Andersen, Katherine S Ryan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mostafa HagarDepartment of Chemistry, The University of British Columbia, Vancouver, British Columbia Canada V6T 1Z4.ORCID 0009-0004-6369-6567
Kalindi D MorganDepartment of Chemistry, The University of British Columbia, Vancouver, British Columbia Canada V6T 1Z4.
Spencer D StumpfDepartment of Biology, Washington University in St Louis, St Louis Missouri 63122, United States.
Maya TsingosDepartment of Biology, Washington University in St Louis, St Louis Missouri 63122, United States.ORCID 0009-0009-3763-3251
Carmen A BanuelosDepartment of Genome Sciences, BC Cancer, Vancouver, British Columbia Canada V5Z 1L3.
Marianne D SadarDepartment of Genome Sciences, BC Cancer, Vancouver, British Columbia Canada V5Z 1L3.ORCID 0000-0003-0599-9215
Joshua A V BlodgettDepartment of Biology, Washington University in St Louis, St Louis Missouri 63122, United States.
Raymond J AndersenDepartment of Chemistry, The University of British Columbia, Vancouver, British Columbia Canada V6T 1Z4.ORCID 0000-0002-7607-8213
Katherine S RyanDepartment of Chemistry, The University of British Columbia, Vancouver, British Columbia Canada V6T 1Z4.ORCID 0000-0003-1643-1940

Funding

Novel compounds that inhibit transactivation of N-terminal domain of the androgenR01CA105304 · NCI · PROVINCIAL HEALTH SERVICES AUTHORITY · PI SADAR, MARIANNE D · 2004 to 2021
$3.7M
NCI NIH HHS R01 CA105304
6 · The paper itself

Abstract

Hybrid genome-mining/

Indexed as

Escherichia coliMethicillin-Resistant Staphylococcus aureusStreptomycesAlanineAnti-Bacterial AgentsAntineoplastic AgentsCell Line, TumorDrug Screening Assays, AntitumorHumansMicrobial Sensitivity TestsMolecular StructurePeptidesPyridazinesAlanineAnti-Bacterial AgentsAntineoplastic AgentsPeptidespiperazic acidPyridazines

Identifiers

PMID38718303
PMCPMC12136074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.